{
  "anumber": "A58718608",
  "id": "A58718608_0055",
  "page_index": 55,
  "resources": {
    "full_jpg": "https://dctn4zjpwgdwdiiy5odjv7o2se0bqgjb.lambda-url.us-east-1.on.aws/iiif/3/og-2023-kc-nara_A58718608_0055/full/max/0/default.jpg"
  },
  "fields": {
    "doctype": {
      "ms_doctype_v1": "form"
    },
    "form_title": {
      "ms_form_title_llm_v1": "Public Health Service Form 2, DS-253"
    },
    "years": {
      "ms_years_nlp_v1": [
        2007,
        2023
      ]
    }
  },
  "is_g325a": false,
  "is_cert_naturalization": false,
  "full_text": "Screened by NARA, 9/13/2023 (3) Immunizations (see Vaccination F check all boxes that apply) Not required fc fugee applicants. Vaccine history complete Vaccine history incomplete, requesting waiver (indicate type below) Incomplete vaccine history, no waiver requested Blanket waiver Individual waiver I certify that I understand the purpose of the medical examination and I authorize the required tests to be completed. Dr. MICHEL HEARD 01 FEB 2007 Applicant Signature VISAParte PhysiciansSignature Date (mm-dd-yyyy) 31 Ave Charles Summer, Port au-prince, Haili Tel. Tel/F x: (509) 245- 0583/(509)245-4545 - (4) Tuberculosis Treatment Regimen (Fill out if applicant has taken in the past, or is now taking TB medication. If drug doses or dates not known or not available, mark \"unknown\".) Check if therapy currently prescribed (if current, don't mark \"End Date Medication Dose/Interval Start Date End Date (i.e. mg/day) (mm-dd-yyyy) (mm-dd-yyyy) Isonaizid (INH) Rifampin Pyrazinamide Ethambutol Streptomycin Other, specify Applicant's weight (kg) Remarks PAPERWORK REDUCTION ACT AND PRIVACY ACT NOTICES Public reporting burden for this collection of information is estimated to average 10 minutes per response including time required for searching existing data sources, gathering the necessary data, providing the information required, and reviewing the final collection. Persons are not required to provide this information in the absence of a valid OMB approval number. Send comments on the accuracy of this estimate of the burden and recommendations for reducing it to: Department of State (A/RPS/DIR) Washington, DC 20520 We ask for information on this form, in the case of applicants for immigrant visas, to determine medical eligibility under INA Sections 212(a) and 221(d), and, in the case of refugees, as required under INA Section 412(b)(4) and (5). If an immigrant visa is issued or refugee status granted , you will convey this form to the INS for disclosure to the Center for Disease Control and the US Public Health Service. Failure to provide this information may delay or prevent the processing of your case. If an immigrant visa is not issued or refugee status is not granted, this form will be treated as confidential under INA Section 222(f). DS-2053 Page 2 of 2"
}